IBC's Outsourcing Manufacturing of Biopharmaceuticals conference provides you insights into developing your risk-mitigation strategies and operational excellence that oversees supply chain security and raw material reliability, thereby delivering a successful agent-sponsor relationship and ensuring consistent high quality products from your CMO partners.
- Compliance audit and quality oversight – meeting the agency’s expectations
- Improving the manufacturing processes through partnership with CMOs
- Opportunities for co-development in cell therapies
- Leveraging simulation tools for optimal resource planning and capacity utilization
- Applying operational excellence and performance measurement to contract manufacturing
- Raw material evaluation and qualification: moving from development into commercial
Keynote Presentations
David Chang, Ph.D.
Senior Director, Global Biologics Manufacturing Science & Technology
Genentech, Inc., a member of the Roche group
Greg Liposky, Ph.D.
Vice President & General Manager, Site Operations
MedImmune
Featured Presentation
Jean-Louis Dasseux, Ph.D.
Chief Executive Officer
Cerenis Therapeutics
- Compliance Audit & Quality Oversight
- Co-Development with CMOs for Enhanced Technology or Innovation
- Modeling/Simulation Tools for Plant Optimization
- Ensuring Partnership Success During Technology Transfer
- Strategies for External Manufacturing and Measuring its KPI
- Supply Chain Risk Management
- Evaluation and Quality Management of Supplier-Derived Raw Materials
» View the agenda